Side-by-side financials for ENSC and LLY. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ENSC | LLY |
|---|---|---|
| Market cap | - | $1.070 T |
| US-listed rank | - | #10 |
| Revenue (latest FY) | $5.07M | $65.18B |
| Net income (latest FY) | $4.31M | $20.64B |
| Net margin | 85.1% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 529 | 989 |
In their latest fiscal years, Ensysce Biosciences, Inc. reported $5.07M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Ensysce Biosciences, Inc. and ELI LILLY & Co, or browse the full rankings.